RheoCarti receives CHF150,000 Venture Kick support
The ETH Zurich spinout is developing a titanium and hydrogel implant surface designed to behave more like natural cartilage.
RheoCarti is advancing an ETH Zurich implant-research project toward preclinical validation.
Veterinary hip replacement is an initial development route before later human joint-replacement work. The financing supports development readiness rather than a marketed clinical product.
Use of funds
Team growth
Manufacturing and quality readiness
Market development